Clinical Trial Update: A Study of MQ710 With and Without Pembrolizumab in People With Solid Tumor Cancer [Phase 1]

View source ↗

Summary

Phase 1 clinical trial evaluating MQ710 with and without pembrolizumab in solid tumors; the study is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Angiosarcoma
• Basal Cell Carcinoma
• Cutaneous Squamous Cell Carcinoma
• Extramammary Paget Disease
• Head and Neck Squamous Cell Carcinoma
• Kaposi Sarcoma
• Melanoma
• Merkel Cell Carcinoma

Drugs mentioned

• MQ710
• Pembrolizumab (pembrolizumab)

Snippet

Sponsor: Memorial Sloan Kettering Cancer Center | Conditions: Cutaneous Squamous Cell Carcinoma, SCC - Squamous Cell Carcinoma | Phase 1 | Status: RECRUITING